MedPath

Innovation Medical Management Co .,Ltd.

๐Ÿ‡จ๐Ÿ‡ณChina
Ownership
-
Established
2003-09-30
Employees
36
Market Cap
-
Website
www.chxyl.com
Introduction

The company was founded in April 1997, completed its initial public offering of shares and listed on September 25, 2007. As the reform of the medical service industry continues to deepen, excellent private hospitals will achieve rapid development, and the profitability of target hospitals will continue to increase steadily in subsequent years. After the transaction is completed, the injection of high-quality assets will greatly enhance the profitability of listed companies, thereby maximizing shareholder value. The company is a listed company whose main business is providing medical services. Corporate honors: It won the third prize for the application of new medical and health technology at the provincial level in 2018, etc.

Clinical Trials

51

Active:0
Completed:43

Trial Phases

1 Phases

Phase 4:47

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (47 trials with phase data)โ€ข Click on a phase to view related trials

Phase 4
47 (100.0%)

Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity

Phase 4
Conditions
Dry Eye
Interventions
First Posted Date
2011-06-30
Last Posted Date
2012-06-14
Lead Sponsor
Innovative Medical
Target Recruit Count
40
Registration Number
NCT01386073
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Jackson Eye, S.C, Lake Villa, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

Pepose Vision Institute, Chesterfield, Missouri, United States

Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract Surgery

Phase 4
Completed
Conditions
Cataracts
First Posted Date
2011-06-28
Last Posted Date
2012-02-17
Lead Sponsor
Innovative Medical
Target Recruit Count
29
Registration Number
NCT01383057
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Loden Vision Centers, Goodlettsville, Tennessee, United States

Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms

Phase 4
Conditions
Dry Eye Syndromes
Interventions
Drug: Altaire Gel forming solution
First Posted Date
2011-06-27
Last Posted Date
2012-06-14
Lead Sponsor
Innovative Medical
Target Recruit Count
100
Registration Number
NCT01382810
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Jackson Eye, SC, Lake Villa, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

Koch Eye Associates, Warwick, Rhode Island, United States

Show Improved Vision With the HOYA AF-1 Aspheric Intraocular Lens After Cataract Surgery

Phase 4
Conditions
Cataracts
First Posted Date
2011-06-27
Last Posted Date
2011-10-06
Lead Sponsor
Innovative Medical
Target Recruit Count
20
Registration Number
NCT01382641
Locations
๐Ÿ‡บ๐Ÿ‡ธ

McDonald Eye Associates, PA, Fayetteville, Arkansas, United States

Laser Cataract Surgery With the Femtosecond Laser Technology

Phase 4
Completed
Conditions
Cataracts
First Posted Date
2011-06-27
Last Posted Date
2011-10-06
Lead Sponsor
Innovative Medical
Target Recruit Count
10
Registration Number
NCT01382823
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Loden Vision Centers, Goodlettsville, Tennessee, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

News

China Establishes Initial Pricing Mechanism for New Drugs to Boost Innovation Returns

China's National Healthcare Security Administration has officially established an initial pricing mechanism for newly launched drugs, marking a shift from cost-control to innovation-encouraging healthcare policies.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.